Lanadelumab Injection

Functions and indications:
For the treatment of patients aged 12 years and above to prevent attacks of hereditary angioedema (HAE).
Adverse reactions:
The most common adverse reactions are injection site reactions, mainly including pain, erythema and bruising at the injection site, as well as upper respiratory tract infection, headache, rash, myalgia, dizziness and diarrhea.
Contraindications:
Patients who are allergic to any ingredient in this product are prohibited